Among MD Anderson honors at National Philanthropy Day in November 2012:
- Outstanding Fundraising Program (larger than $250,000): Making Cancer History®: The Campaign to Transform Cancer Care
- Past MD Anderson President John Mendelsohn, M.D., now co-director of the Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, accepted the award on behalf of MD Anderson. He was at the helm when the campaign hit its original $1 billion goal two years ahead of schedule, ending the campaign early, in December 2011, at a total of $1.215 billion.
- Byron Welch Award for Lifetime Achievement in Fundraising: Patrick Mulvey, vice president for development
- Mulvey began his career in fundraising at his alma mater, the University of St. Thomas. He arrived at MD Anderson in 1985, starting as assistant director for Development Services and going on to hold several positions through the years before taking on his current leadership role in 2000.
- M. Anne Murphy Award for Outstanding Professional Advancement: Michael Delzotti, director of philanthropic resources
- Delzotti began his career in health care administration and has worked in development at the University of California, Los Angeles; Special Olympics Southern California; and Rice University.
More Stories From Promise
A message from Dr. DePinho
A word from the president
A bright future for philanthropy
Young donors reflect the heart of giving
Mexico, Texas institutions wage war on tobacco
Collaboration engages moon shot cancer prevention and control platform
Seminar offers a glimpse at the moon shot play book
Guests encouraged to be part of the game plan
Leading gifts lay groundwork for Moon Shots Program
MD Anderson's Moon Shots Program, an aggressive, milestone-driven effort initially targeting eight cancers, relies on private philanthropy as a crucial source of funding.
Beating the odds
It's been said that the early bird catches the worm. The old English proverb, stressing the 15th-century virtues of hard work and perseverance, is still a mantra for modern times. Just ask 21st century MD Anderson researchers, clinicians, surgeons and scientists intent on more effectively preventing, detecting and treating cancer - the earlier the better.
Triumph Over Kid Cancer Foundation
Teen on a mission to 'make it better' for others
In 2001, Anthony Pistone of West Palm Beach, Fla. received a diagnosis of chronic lymphocytic leukemia. His wife, Lorie, reflects on their cancer journey at MD Anderson and finds a silver lining to share.
John Webb retired in 1996 as president of Exxon Chemical Americas. He is a three-time cancer survivor and longtime MD Anderson supporter. He and his wife, Francine, live in Austin
AT&T donation helps teens stay connected
A group of 18 MD Anderson cancer patients and survivors formed imPACT (Patient Advisory Council for Teens) last fall, partnering with hospital staff in the decision-making process and working together on patient care projects.
Blackjack players hit it big in fight against cancer
The Hampton Post Oak Blackjack Club recently donated $500 to MD Anderson
Motorcycle group revs up brain cancer research
Sam's Jam honors late MD Anderson neurosurgeon
Unconventional fundraising idea rocks
Rod Ryan Show t-shirt sales benefit cancer research
San Antonio A Conversation With a Living Legend®
Former President George W. Bush honored
Santa's Elves spread holiday joy
Annual event benefits pediatric programs
BISH Foundation creates hope from loss
Inspiration spurs fight against ovarian cancer
Mulvas fund lifesaving melanoma research
Conference center named in couple's honor
Safeway supports groundbreaking breast cancer research
I-SPY 2 trial aims to speed new therapies to clinic
A new approach to Alzheimer's
Belfer Family Foundation's $25 million gift establishes unique research consortium
MD Anderson, GlaxoSmithKline working on cancer immune therapy in $335M deal
MD Anderson and the global pharmaceutical company GlaxoSmithKline (GSK) will jointly conduct research leading to new therapeutic antibodies that help the immune system fight cancer.
Depression, stress key factors in bladder cancer outcomes
Recent MD Anderson research reveals that depression and certain age-related biomarkers could affect a bladder cancer patient's disease progression and likelihood of survival.
Project to sort cancer-causing cellular chaos wins innovator award
Nicholas Navin, Ph.D., receives Damon Runyon-Rachleff Innovation Award
Stress triggers signaling pathway that leads to spread of ovarian cancer
MD Anderson scientists have discovered the signaling pathway whereby a master regulator of cancer cell proteins - known as Src - leads to ovarian cancer progression when exposed to stress hormones.
Breast cancer patients benefit from qigong
An ancient Chinese practice could make life better for women undergoing treatment for breast cancer.